The Latest Breaking News from BioNTech

Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.

The immunologist who runs Scancell is trialling novel treatments to attack tumours, as well as needle-free Covid jabs

Here’s a look at the status of mRNA technology's application in cancer and when it might reach patients.

BioNTech said Friday almost a third of patients with a hard-to-treat form of lung cancer responded to its treatment — and BNTX stock popped.

Top U.N. officials and health industry leaders are trying to tackle an alarming surge in tuberculosis, which is now killing more people worldwide than COVID-19 or AIDS

BioNTech crushed Wall Street's profit views Monday, but shares dipped at the close amid expectations for more drops in Covid vaccine sales.

Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay half price, or about 10 euros ($11), for each of about 70 million cancelled doses, the Financial Times reported on Sunday. The revised contract would allow…

Experts hope new vaccines will be ready by end of decade

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases

BioNTech said Monday it expects roughly $5.4 billion in sales of its Covid shot this year, missing views and leading BNTX stock to tumble.

Six mobile vaccine-production units developed by German pharmaceutical company BioNTech have arrived in Rwanda. This is the first such shipment to Africa as the continent seeks to boost local production of mRNA vaccines.